MedPath

prophylactic antibiotics on surgical site infections in elective laparoscopic cholecystectomy.

Phase 3
Conditions
Surgical site infection.
Infection following a procedure, not elsewhere classified
Registration Number
IRCT20180615040107N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
76
Inclusion Criteria

Patients with symptomatic gallstone
Patients candidate for elective laparoscopic cholecystectomy
Patient under 75 years old

Exclusion Criteria

Patients who received antibiotics in the few days before surgery
Patients with CBD stone or cholecystitis
Patients with a history of diabetes
Patients with using drugs that affect the immune system

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surgical site infection involves redness and swelling of the wound or purulent discharge. Timepoint: 24 hours after surgery and 4 to 7, 10 to 15 and 30 days after surgery. Method of measurement: Clinical.
Secondary Outcome Measures
NameTimeMethod
Respiratory infection. Timepoint: 24 to 72 hours after surgery. Method of measurement: Clinical.;Fever& chills. Timepoint: 24 to 72 hours after surgery. Method of measurement: Clinical.
© Copyright 2025. All Rights Reserved by MedPath